» Articles » PMID: 28359822

Computational and Experimental Approaches for Development of Methotrexate Nanosuspensions by Bottom-up Nanoprecipitation

Overview
Journal Int J Pharm
Specialties Chemistry
Pharmacology
Date 2017 Apr 1
PMID 28359822
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Development of nanosuspensions offers a promising tool for formulations involving poorly water-soluble drugs. In this study, methotrexate (MTX) nanosuspensions were prepared using a bottom-up process based on acid-base neutralization reactions. Computational studies were performed to determine structural and electronic properties for isolated molecules and molecular clusters in order to evaluate the mechanism of MTX nanoparticle formation. Computational results indicated that the clusters in zwitterionic and cationic states presented larger dimensions and higher energies of interaction between MTX molecules, which favored aggregation. In contrast, the clusters in the anionic state exhibited lower energies of interaction, indicating aggregation was less likely to occur. Experimental results indicated that the higher the HCl proportion during drug precipitation, the greater the particle size, resulting in micrometric particles (2874-7308nm) (cationic and zwitterionic forms). However, MTX nanoparticles ranging in size from 132 to 186nm were formed using the lowest HCl proportion during drug precipitation (anionic form). In vitro release profiles indicated that the drug release rate from nanosuspension was increased (approximately 2.6 times) over that of the raw material. Overall, computational modeling and experimental analysis were complementary and assisted in the rational design of the nanosuspension based on acid-base reactions.

Citing Articles

Tailoring Mesalazine Nanosuspension Using Chitosan Polyelectrolyte Complexes with Alginate and Alginate/Hydroxypropyl-Methylcellulose Phthalate.

Pereira A, Aparecida J, Ramalho M, Ferreira L, Gremiao M Pharmaceutics. 2025; 16(12.

PMID: 39771469 PMC: 11676705. DOI: 10.3390/pharmaceutics16121489.


Utilizing Molecular Simulations to Examine Nanosuspension Stability.

Latham A, Levy E, Sellers B, Leung D Pharmaceutics. 2024; 16(1).

PMID: 38258061 PMC: 11154398. DOI: 10.3390/pharmaceutics16010050.


Development of Nanosuspension of Extract as Novel Drug Delivery System to Enhance Its Bioavailability and Hepatoprotective Potential.

Jahan N, Kousar F, Rahman K, Touqeer S, Abbas N J Funct Biomater. 2023; 14(8).

PMID: 37623677 PMC: 10456093. DOI: 10.3390/jfb14080433.


Dissolving microneedle patch-assisted transdermal delivery of methotrexate improve the therapeutic efficacy of rheumatoid arthritis.

Zhao W, Zheng L, Yang J, Ma Z, Tao X, Wang Q Drug Deliv. 2022; 30(1):121-132.

PMID: 36533887 PMC: 9769132. DOI: 10.1080/10717544.2022.2157518.


Development of Methotrexate Complexes Endowed with New Biological Properties Envisioned for Musculoskeletal Regeneration in Rheumatoid Arthritis Environments.

Fernandez-Villa D, Ramirez-Jimenez R, Aranaz I, Acosta N, Vazquez-Lasa B, Rojo L Int J Mol Sci. 2022; 23(17).

PMID: 36077450 PMC: 9456012. DOI: 10.3390/ijms231710054.